Home
>
National Drug Code (NDC)
>
TIGAN
TIGAN - 61570-079-01 - (trimethobenzamide hydrochloride)
Drug Information of TIGAN
| Product NDC: | 61570-079 |
| Proprietary Name: | TIGAN |
| Non Proprietary Name: | trimethobenzamide hydrochloride |
| Active Ingredient(s): | 300 mg/1 & nbsp; trimethobenzamide hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of TIGAN
| Product NDC: | 61570-079 |
| Labeler Name: | Monarch Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA017531 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20011213 |
Package Information of TIGAN
| Package NDC: | 61570-079-01 |
| Package Description: | 100 CAPSULE in 1 BOTTLE (61570-079-01) |
NDC Information of TIGAN
| NDC Code | 61570-079-01 |
| Proprietary Name | TIGAN |
| Package Description | 100 CAPSULE in 1 BOTTLE (61570-079-01) |
| Product NDC | 61570-079 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | trimethobenzamide hydrochloride |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20011213 |
| Marketing Category Name | NDA |
| Labeler Name | Monarch Pharmaceuticals, Inc. |
| Substance Name | TRIMETHOBENZAMIDE HYDROCHLORIDE |
| Strength Number | 300 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Antiemetic [EPC],Emesis Suppression [PE] |
